Blood Advances (Nov 2019)
Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients
- Margherita Maffioli,
- Toni Giorgino,
- Barbara Mora,
- Alessandra Iurlo,
- Elena Elli,
- Maria Chiara Finazzi,
- Marianna Caramella,
- Elisa Rumi,
- Maria Cristina Carraro,
- Nicola Polverelli,
- Mariella D'Adda,
- Simona Malato,
- Marianna Rossi,
- Alfredo Molteni,
- Alessandro Vismara,
- Cinzia Sissa,
- Francesco Spina,
- Michela Anghilieri,
- Daniele Cattaneo,
- Rossella Renso,
- Marta Bellini,
- Maria Luisa Pioltelli,
- Chiara Cavalloni,
- Daniela Barraco,
- Raffaella Accetta,
- Lorenza Bertù,
- Matteo Giovanni Della Porta,
- Francesco Passamonti
Affiliations
- Margherita Maffioli
- Hematology Unit, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy;
- Toni Giorgino
- Biophysics Institute (IBF-CNR), National Research Council of Italy, Milan, Italy;; Department of Biosciences, University of Milan, Milan, Italy;
- Barbara Mora
- Hematology Unit, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy;
- Alessandra Iurlo
- Hematology Division, Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy;
- Elena Elli
- Hematology Division and Bone Marrow Unit, Ospedale San Gerardo, Monza, Italy;
- Maria Chiara Finazzi
- Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy;
- Marianna Caramella
- Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;
- Elisa Rumi
- Department of Molecular Medicine, University of Pavia, Pavia, Italy;
- Maria Cristina Carraro
- Hematology and Transfusional Medicine Unit, ASST Fatebenefratelli Sacco, Milan, Italy;
- Nicola Polverelli
- Unit of Blood Diseases and Stem Cell Transplantation, ASST Spedali Civili di Brescia, Brescia, Italy;
- Mariella D'Adda
- Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy;
- Simona Malato
- Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;
- Marianna Rossi
- Department of Hematology, Cancer Center, IRCCS Humanitas Research Hospital/Humanitas University, Rozzano, Italy;
- Alfredo Molteni
- Hematology Unit, ASST Cremona, Cremona, Italy;
- Alessandro Vismara
- Onco-Hematology Unit, ASST-Rhodense, Rho, Italy;
- Cinzia Sissa
- Department of Hematology and Transfusion Medicine, ASST Mantova, Mantova, Italy;
- Francesco Spina
- Hematology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;
- Michela Anghilieri
- Oncology Department, ASST Lecco, Lecco, Italy;
- Daniele Cattaneo
- Hematology Division, Foundation Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy;
- Rossella Renso
- Hematology Division and Bone Marrow Unit, Ospedale San Gerardo, Monza, Italy;
- Marta Bellini
- Department of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy;
- Maria Luisa Pioltelli
- Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy;
- Chiara Cavalloni
- Department of Molecular Medicine, University of Pavia, Pavia, Italy;
- Daniela Barraco
- Hematology Unit, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy;
- Raffaella Accetta
- Cytogenetics and Genetics Laboratory, Ospedale di Circolo, ASST Sette Laghi, Varese, Italy
- Lorenza Bertù
- Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi–Ospedale di Circolo, Varese, Italy
- Matteo Giovanni Della Porta
- Department of Hematology, Cancer Center, IRCCS Humanitas Research Hospital/Humanitas University, Rozzano, Italy;
- Francesco Passamonti
- Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi–Ospedale di Circolo, Varese, Italy; Francesco Passamonti, Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Viale L. Borri 57, 21100 Varese, Italy;
- Journal volume & issue
-
Vol. 3,
no. 21
pp. 3196 – 3200